“Stem Cell Sector Needs a Viable Product to Spark Investor Interest”
“Ferghana Partners Advised Schering AG on Refludan Transaction with Pharmion”
“Stem Cell Sector Needs a Viable Product to Spark Investor Interest”
“Ferghana Partners Advised Schering AG on Refludan Transaction with Pharmion”